Dingjie Xu

517 total citations
24 papers, 404 citations indexed

About

Dingjie Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Dingjie Xu has authored 24 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Dingjie Xu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Occupational and environmental lung diseases (10 papers) and Peptidase Inhibition and Analysis (4 papers). Dingjie Xu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Occupational and environmental lung diseases (10 papers) and Peptidase Inhibition and Analysis (4 papers). Dingjie Xu collaborates with scholars based in China, United States and Australia. Dingjie Xu's co-authors include Hong Xu, Xuemin Gao, Shifeng Li, Zhongqiu Wei, Fang Yang, Wenchen Cai, Lijuan Zhang, Na Mao, Fuyu Jin and Heliang Liu and has published in prestigious journals such as Scientific Reports, Journal of Cell Science and Experimental Cell Research.

In The Last Decade

Dingjie Xu

24 papers receiving 400 citations

Peers

Dingjie Xu
K. Oliva Australia
Jian Gu China
Tadeja Kuret Slovenia
Anal Desai United States
Magda Wolna United Kingdom
K. Oliva Australia
Dingjie Xu
Citations per year, relative to Dingjie Xu Dingjie Xu (= 1×) peers K. Oliva

Countries citing papers authored by Dingjie Xu

Since Specialization
Citations

This map shows the geographic impact of Dingjie Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingjie Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingjie Xu more than expected).

Fields of papers citing papers by Dingjie Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingjie Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingjie Xu. The network helps show where Dingjie Xu may publish in the future.

Co-authorship network of co-authors of Dingjie Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Dingjie Xu. A scholar is included among the top collaborators of Dingjie Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingjie Xu. Dingjie Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Tian, Na Mao, Jianing Wang, et al.. (2024). Paeoniflorin mitigates MMP-12 inflammation in silicosis via Yang-Yin-Qing-Fei Decoction in murine models. Phytomedicine. 129. 155616–155616. 7 indexed citations
2.
Li, Hui, Huan Zhang, Xiaoxi Wei, et al.. (2024). The mitochondria-targeted antioxidant MitoQ ameliorates inorganic arsenic-induced DCs/Th1/Th2/Th17/Treg differentiation partially by activating PINK1-mediated mitophagy in murine liver. Ecotoxicology and Environmental Safety. 277. 116350–116350. 10 indexed citations
3.
Li, Tian, Xinyu Yang, Dingjie Xu, et al.. (2021). OC‐STAMP Overexpression Drives Lung Alveolar Epithelial Cell Type II Senescence in Silicosis. Oxidative Medicine and Cellular Longevity. 2021(1). 4158495–4158495. 13 indexed citations
4.
Jin, Fuyu, Dingjie Xu, Yaqian Li, et al.. (2021). Ac-SDKP Attenuates Activation of Lung Macrophages and Bone Osteoclasts in Rats Exposed to Silica by Inhibition of TLR4 and RANKL Signaling Pathways. Journal of Inflammation Research. Volume 14. 1647–1660. 18 indexed citations
5.
Cao, Ying, et al.. (2020). Letrozole and the Traditional Chinese Medicine, Shaofu Zhuyu Decoction, Reduce Endometriotic Disease Progression in Rats: A Potential Role for Gut Microbiota. Evidence-based Complementary and Alternative Medicine. 2020(1). 3687498–3687498. 26 indexed citations
6.
Gao, Xuemin, Hong Xu, Dingjie Xu, et al.. (2020). MiR-411–3p alleviates Silica-induced pulmonary fibrosis by regulating Smurf2/TGF-β signaling. Experimental Cell Research. 388(2). 111878–111878. 26 indexed citations
7.
Li, Shifeng, Dingjie Xu, Na Mao, et al.. (2020). Silica Perturbs Primary Cilia and Causes Myofibroblast Differentiation during Silicosis by Reduction of the KIF3A-Repressor GLI3 Complex. Theranostics. 10(4). 1719–1732. 14 indexed citations
8.
Gao, Xuemin, Dingjie Xu, Shumin Li, et al.. (2020). Pulmonary Silicosis Alters MicroRNA Expression in Rat Lung and miR-411-3p Exerts Anti-fibrotic Effects by Inhibiting MRTF-A/SRF Signaling. Molecular Therapy — Nucleic Acids. 20. 851–865. 36 indexed citations
9.
Wei, Zhongqiu, Hong Xu, Yi Xue, et al.. (2019). Rho GDP dissociation inhibitor α silencing attenuates silicosis by inhibiting RhoA/Rho kinase signalling. Experimental Cell Research. 380(2). 131–140. 13 indexed citations
10.
Zhang, Bonan, Hong Xu, Yi Xue, et al.. (2019). Targeting the RAS axis alleviates silicotic fibrosis and Ang II-induced myofibroblast differentiation via inhibition of the hedgehog signaling pathway. Toxicology Letters. 313. 30–41. 9 indexed citations
11.
Chen, Yingying, Dingjie Xu, Zhongqiu Wei, et al.. (2019). Inhibition of miR-155-5p Exerts Anti-Fibrotic Effects in Silicotic Mice by Regulating Meprin α. Molecular Therapy — Nucleic Acids. 19. 350–360. 31 indexed citations
12.
Li, Shifeng, Hong Xu, Yi Xue, et al.. (2019). Ac-SDKP increases α-TAT 1 and promotes the apoptosis in lung fibroblasts and epithelial cells double-stimulated with TGF-β1 and silica. Toxicology and Applied Pharmacology. 369. 17–29. 31 indexed citations
13.
Mao, Na, Hong Xu, Fuyu Jin, et al.. (2019). Proteomic profile of TGF-β1 treated lung fibroblasts identifies novel markers of activated fibroblasts in the silica exposed rat lung. Experimental Cell Research. 375(2). 1–9. 12 indexed citations
14.
Zhang, Lijuan, Dingjie Xu, Qian Li, et al.. (2018). N -acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) attenuates silicotic fibrosis by suppressing apoptosis of alveolar type II epithelial cells via mediation of endoplasmic reticulum stress. Toxicology and Applied Pharmacology. 350. 1–10. 30 indexed citations
15.
Zhang, Hui, Dingjie Xu, Yuan Yuan, et al.. (2018). Silicosis decreases bone mineral density in rats. Toxicology and Applied Pharmacology. 348. 117–122. 12 indexed citations
16.
Zhu, Guanghui, et al.. (2018). Shaofu Zhuyu Decoction Regresses Endometriotic Lesions in a Rat Model. Evidence-based Complementary and Alternative Medicine. 2018(1). 3927096–3927096. 11 indexed citations
17.
Liu, Yan, Hong Xu, Dingjie Xu, et al.. (2017). Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis. Respiratory Research. 18(1). 38–38. 42 indexed citations
18.
Wang, Xiaojun, Yan Liu, Hong Xu, et al.. (2016). Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica. Scientific Reports. 6(1). 32257–32257. 24 indexed citations
19.
Li, Shifeng, Xuemin Gao, Dingjie Xu, et al.. (2015). [Inhibition effect of N-acetyl-seryl-aspartyl-lysyl-proline on myofibroblast differentiation by regulating acetylated tubulin α in silicotic rat model].. PubMed. 33(11). 816–21. 2 indexed citations
20.
Li, Shifeng, Xinxin Xue, Dingjie Xu, et al.. (2014). [Inhibition effect of N-acetyl-seryl-aspartyl-lysyl-proline on myofibroblast differentiation of MRC-5 human fetal lung fibroblasts inuced by Ang II].. PubMed. 32(11). 801–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026